OnKure Therapeutics, Inc. - OKUR

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Aug 14, 2026 SCHEDULE 13G/A BIOTECHNOLOGY VALUE FUND L P 4.1% 1,671,617 View
Aug 14, 2026 SCHEDULE 13G/A BVF I GP LLC 4.1% 1,671,617 View
Aug 14, 2026 SCHEDULE 13G/A BIOTECHNOLOGY VALUE FUND II LP 3.2% 1,289,385 View
Aug 14, 2026 SCHEDULE 13G/A BVF II GP LLC 3.2% 1,289,385 View
Aug 14, 2026 SCHEDULE 13G/A Biotechnology Value Trading Fund OS LP 0.6% 226,497 View
Aug 14, 2026 SCHEDULE 13G/A BVF Partners OS Ltd. 0.6% 226,497 View
Aug 14, 2026 SCHEDULE 13G/A BVF GP HOLDINGS LLC 7.3% 2,961,002 View
Aug 14, 2026 SCHEDULE 13G/A BVF PARTNERS L P/IL 8.0% 3,235,778 View
Aug 14, 2026 SCHEDULE 13G/A BVF INC/IL 8.0% 3,235,778 View
Aug 14, 2026 SCHEDULE 13G/A LAMPERT MARK N 8.0% 3,235,778 View
Aug 14, 2026 SCHEDULE 13G/A ADAR1 Capital Management, LLC 5.5% 2,238,684 View
Aug 14, 2026 SCHEDULE 13G/A ADAR1 Capital Management GP, LLC 4.5% 1,832,117 View
Aug 14, 2026 SCHEDULE 13G/A Daniel Schneeberger 5.5% 2,238,684 View
Aug 14, 2026 SCHEDULE 13G/A Trails Edge Capital Partners, LP 3.6% 1,438,456 View
Aug 14, 2026 SCHEDULE 13G/A Trails Edge Biotechnology Master Fund, LP 3.6% 1,438,456 View
Aug 14, 2026 SCHEDULE 13G/A Ortav Yehudai 3.6% 1,438,456 View
Aug 10, 2026 SCHEDULE 13G/A Prosight Management, LP 2.4% 978,992 View
Aug 10, 2026 SCHEDULE 13G/A Prosight Fund, LP 0.1% 45,771 View
Aug 10, 2026 SCHEDULE 13G/A Prosight Plus Fund, LP 0.5% 219,725 View
Aug 10, 2026 SCHEDULE 13G/A Prosight Partners, LLC 2.4% 978,992 View
Aug 10, 2026 SCHEDULE 13G/A W. Lawrence Hawkins 2.4% 978,992 View
May 27, 2026 SCHEDULE 13G BIOTECHNOLOGY VALUE FUND L P 2.7% 1,095,373 View
May 27, 2026 SCHEDULE 13G BVF I GP LLC 2.7% 1,095,373 View
May 27, 2026 SCHEDULE 13G BIOTECHNOLOGY VALUE FUND II LP 2.1% 854,705 View
May 27, 2026 SCHEDULE 13G BVF II GP LLC 2.1% 854,705 View
May 27, 2026 SCHEDULE 13G Biotechnology Value Trading Fund OS LP 0.4% 153,595 View
May 27, 2026 SCHEDULE 13G BVF Partners OS Ltd. 0.4% 153,595 View
May 27, 2026 SCHEDULE 13G BVF GP HOLDINGS LLC 4.8% 1,950,078 View
May 27, 2026 SCHEDULE 13G BVF PARTNERS L P/IL 5.3% 2,134,908 View
May 27, 2026 SCHEDULE 13G BVF INC/IL 5.3% 2,134,908 View
May 27, 2026 SCHEDULE 13G LAMPERT MARK N 5.3% 2,134,908 View
May 15, 2026 SCHEDULE 13G/A ADAR1 Capital Management, LLC 6.0% 2,434,941 View
May 15, 2026 SCHEDULE 13G/A ADAR1 Capital Management GP, LLC 5.0% 2,038,429 View
May 15, 2026 SCHEDULE 13G/A Daniel Schneeberger 6.0% 2,434,941 View
Apr 07, 2026 SCHEDULE 13D — 19.99% 3,998,332 View
Apr 07, 2026 SCHEDULE 13G StepStone Group LP 6.6% 2,660,612 View
Apr 07, 2026 SCHEDULE 13G StepStone Master G, L.P. 6.6% 2,660,612 View
Apr 07, 2026 SCHEDULE 13G StepStone VC MI-G GP, LLC 6.6% 2,660,612 View
Apr 07, 2026 SCHEDULE 13G Trails Edge Capital Partners, LP 6.0% 2,409,638 View
Apr 07, 2026 SCHEDULE 13G Trails Edge Biotechnology Master Fund, LP 6.0% 2,409,638 View
Apr 07, 2026 SCHEDULE 13G Ortav Yehudai 6.0% 2,409,638 View
Apr 07, 2026 SCHEDULE 13G RA Capital Management, L.P. 9.9% 4,038,715 View
Apr 07, 2026 SCHEDULE 13G Peter Kolchinsky 9.9% 4,038,715 View
Apr 07, 2026 SCHEDULE 13G Rajeev Shah 9.9% 4,038,715 View
Apr 07, 2026 SCHEDULE 13G RA Capital Healthcare Fund, L.P. 9.9% 4,038,715 View
Apr 01, 2026 SCHEDULE 13G ACORN BIOVENTURES, L.P. 4.5% 1,854,525 View
Apr 01, 2026 SCHEDULE 13G ACORN CAPITAL ADVISORS GP, LLC 4.5% 1,854,525 View
Apr 01, 2026 SCHEDULE 13G ACORN BIOVENTURES 2, L.P. 5.0% 2,069,512 View
Apr 01, 2026 SCHEDULE 13G Acorn Capital Advisors GP 2, LLC 5.0% 2,069,512 View
Apr 01, 2026 SCHEDULE 13G Anders Hove 9.5% 3,924,037 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.